Loading stock data…
Surgery Partners (SGRY)
$16.56+0.74 (+4.68%)
After Hours$16.51-0.05 (-0.30%)· Last close Jun 29
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Surgery Partners, Inc. in the Healthcare sector is trading at $16.56 with a market capitalization of $2.0B. Wall Street consensus targets $17.95 (11 analysts), implying a +8.4% move over the next 12 months. The stock is currently 31% below its 52-week high of $24.10, remaining 3.2% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +8.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $810.90M↓ | $885.00M↑ | $821.50M↓ | $826.20M↑ | $776.00M |
| Gross Profit | $160.20M↓ | $212.20M↑ | $195.30M↓ | $195.60M↑ | $161.90M |
| Operating Income | $84.10M↓ | $124.80M↓ | $135.10M↑ | $121.30M↑ | $89.60M |
| Net Income | -$35.90M↓ | -$15.00M↑ | -$22.70M↓ | -$2.50M↑ | -$37.70M |
Peer Comparison
JNJUNHPFE
Fundamentals
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency su...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.00B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-4.51%
Volume
Today's trading volume
1.40M
Recent News
How HCA Stock's Quiet Compounding Changes The Growth Story
With shares lagging and revenue growth slowing, the market seems to be missing the powerful engine driving HCA's per-share earnings higher.
Why Fast-paced Mover Surgery Partners (SGRY) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Surgery Partners (SGRY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Unpacking Q1 Earnings: Surgery Partners (NASDAQ:SGRY) In The Context Of Other Outpatient & Specialty Care Stocks
Looking back on outpatient & specialty care stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Surgery Partners (NASDAQ:SGRY) and its peers.
Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 26.1% in Surgery Partners (SGRY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
3 Reasons to Sell SGRY and 1 Stock to Buy Instead
Surgery Partners currently trades at $15.10 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell short of the S&P 500’s 9.3% gain during that period.